Scarica l'app Stockscreener
360.45
0.81%
-2.94
Dopo l'orario di chiusura:
360.45
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$363.39
Aprire:
$363.04
Volume 24 ore:
1.69M
Relative Volume:
0.64
Capitalizzazione di mercato:
$194.54B
Reddito:
$37.30B
Utile/perdita netta:
$7.80B
Rapporto P/E:
25.07
EPS:
14.3793
Flusso di cassa netto:
$8.60B
1 W Prestazione:
-1.63%
1M Prestazione:
+1.48%
6M Prestazione:
+11.15%
1 anno Prestazione:
+22.07%
Intervallo 1D:
$355.73
$363.29
Intervallo di 1 settimana:
$355.73
$375.25
Portata 52W:
$269.77
$391.29
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, MRK, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
360.45 | 196.12B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
1,181.87 | 1.06T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
257.77 | 618.61B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
248.00 | 438.31B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
124.03 | 305.12B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
153.37 | 293.94B | 54.66B | 13.58B | 16.05B | 7.0171 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Iniziato | Canaccord Genuity | Hold |
| 2026-03-10 | Iniziato | Jefferies | Hold |
| 2026-02-20 | Iniziato | Barclays | Equal Weight |
| 2026-01-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Ripresa | UBS | Buy |
| 2025-12-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2025-11-24 | Ripresa | Truist | Hold |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-09-03 | Ripresa | Raymond James | Mkt Perform |
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Amgen (AMGN) Recalls Corlanor And Sensipar Nationwide Over Quality Control Issues - simplywall.st
Amgen Faces a July 29 Deadline to Save Tavneos From an FDA Withdrawal. Here’s What It Means for the Stock. - TIKR.com
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance Singapore
Guggenheim Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - MarketBeat
Guggenheim raises Amgen stock price target to $343 on product mix - Investing.com
AMGN DCF Analysis: Intrinsic Value $292 vs Price $363 - GuruFocus
BofA raises Amgen stock price target on growth franchise execution By Investing.com - Investing.com Nigeria
BofA raises Amgen stock price target on growth franchise execution - Investing.com
J. Safra Sarasin Holding AG Sells 38,033 Shares of Amgen Inc. $AMGN - MarketBeat
Absher Wealth Management LLC Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - The Motley Fool
Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term story - ad-hoc-news.de
Castleview Partners LLC Has $2.77 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Ferguson Wellman Capital Management Inc. - MarketBeat
Cullinan Associates Inc. Has $8.98 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Fifth Third Bancorp Acquires 167,835 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen stock holds steady as investors await the next catalyst - ad-hoc-news.de
Amgen stock steadies as the biotech group leans on scale - ad-hoc-news.de
Amgen Inc. $AMGN Shares Sold by Torray Investment Partners LLC - MarketBeat
Candriam S.C.A. Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Conning Inc. Has $33.85 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds steady as biotech pipeline and U.S. market listing shape long-term investor expect - ad-hoc-news.de
Amgen's Biotech Crossroads: Congressional Divergence Amid Patent Cliffs and Pipeline Promise - Kavout | AI
ETFs Investing in Amgen Inc. Stocks - TradingView
Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term growth narr - ad-hoc-news.de
Amgen stock reflects biotech heavyweight's steady role in US healthcare - ad-hoc-news.de
Munich Reinsurance Co Stock Corp in Munich Sells 2,916 Shares of Amgen Inc. $AMGN - MarketBeat
Ibex Wealth Advisors Increases Stake in Amgen Inc. $AMGN - MarketBeat
First Horizon Corp Boosts Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Regeneron Cites Medtronic Ruling In Amgen Bundling Case - Law360
Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch
How AI Is Changing Drug Discovery and What It Will Take to Unlock Its Full Potential - Amgen
Truist Raises its Price Target on Amgen (AMGN) - Insider Monkey
Amgen (AMGN): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Amgen stock responds to obesity drug progress and solid pipeline momentum - AD HOC NEWS
Sumitomo Mitsui Trust Group Inc. Lowers Holdings in Amgen Inc. $AMGN - MarketBeat
Greenwood Capital Associates LLC Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen highlights its biotech pipeline as a driver for long-term growth - Ad-hoc-news.de
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $370 - Moomoo
Amgen highlights oncology pipeline progress as a major biotech on Nasdaq - Ad-hoc-news.de
The Future of Genus Patenting Strategies for Antibodies Post- Amgen - IPWatchdog.com
Amgen Ecovation®: How Amgen Builds Sustainability Into Biotech - Amgen
Regeneron Narrows Amgen Challenges in Case Over Eylea Biosimilar - Bloomberg Law News
Amgen extends its biotech footprint as a major U.S. pharma player - Ad-hoc-news.de
Amgen Inc. $AMGN Holdings Cut by Swedbank AB - MarketBeat
Amgen Inc. focuses on biotechnology leadership as investors track long-term growth drivers - Ad-hoc-news.de
Amgen focuses on long-term growth as a leading biotech innovator - Ad-hoc-news.de
Amgen (AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025 summary - Quartr
Regeneron Ducks Amgen's Eylea Antitrust Counterclaims - Law360
How Safe Is Amgen's Dividend? - The Motley Fool
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.40%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):